HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Burgel, P-R. Articles by Nadel, J.A. Search for Related Content PubMed PubMed Citation Articles by Burgel, P-R. Articles by Nadel, J.A.

Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps

¹ Service de Pneumologie, Université René Descartes, Hôpital Cochin, Paris, France. ² Dept of Otorhinolaryngology, Malmö University Hospital, Malmö, Sweden. ³ Cardiovascular Research Institute, and Dept of Medicine and Physiology, University of California, San Francisco, CA, USA.

CORRESPONDENCE: J.A. Nadel, Cardiovascular Research Institute, Box 0130, University of California San Francisco, San Francisco, CA 94 143-0130, USA. Fax: 01 4154762283. E-mail: janadel@itsa.ucsf.edu

Keywords: Airway epithelium, epidermal growth factor receptor, interleukin-8, leukocyte recruitment, mucous hypersecretion, steroid treatment

Received: February 4, 2004
Accepted May 4, 2004

This work was funded by private funds. P-R. Burgel is a recipient of a grant from "Collège des Professeurs de Pneumologie".

Increased mucin expression is a feature of nasal polyposis. Corticosteroids reduce polyp size and symptoms, but their effect on mucin production remains unknown. In this study, the effects of intranasal corticosteroids on MUC5AC mucin expression, nasal resistance, eosinophil and neutrophil infiltration, epidermal growth factor receptor (EGFR), interleukin (IL)-8, and tumour necrosis factor (TNF)- expression was assessed in nasal polyps.

In nine subjects, one nasal polyp was removed surgically before treatment and another was removed after 8 weeks of intranasal fluticasone (400 µg·day^–1). Tissues were processed for in situ hybridisation and immunohistochemical staining. Described effects of fluticasone on nasal polyps (reduction in nasal resistance and in eosinophil infiltration) were evaluated. Morphometric analysis was performed to assess the effect of fluticasone on epithelial-, MUC5AC-, EGFR- and IL-8-stained areas, TNF--stained cells, and neutrophil numbers.

Treatment with fluticasone decreased nasal resistance and intra-epithelial eosinophils. The MUC5AC-stained area in the epithelium was unchanged by treatment; MUC5AC mRNA expression was unaffected by treatment. EGFR-stained area, intra-epithelial neutrophil numbers, IL-8 and TNF- expression were also unchanged by therapy.

Intranasal fluticasone was effective in decreasing nasal airflow resistance and intra-epithelial eosinophils but had no effect on mucin or epidermal growth factor receptor expression or on neutrophil recruitment.

This article has been cited by other articles:

				P.-R. Burgel, D. Montani, C. Danel, D. J Dusser, and J. A Nadel A morphometric study of mucins and small airway plugging in cystic fibrosis Thorax, February 1, 2007; 62(2): 153 - 161. [Abstract] [Full Text] [PDF]

				P. Stjarne, R. Mosges, M. Jorissen, D. Passali, L. Bellussi, H. Staudinger, and M. Danzig A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg, February 1, 2006; 132(2): 179 - 185. [Abstract] [Full Text] [PDF]